Eli Lilly Faces Earnings Miss and Market Challenges Amidst Competitive Pressures
Eli Lilly & Co. reported a first-quarter earnings miss, sending its stock plummeting, amidst intense competition and strategic challenges in the weight-loss drug market.
2 minutes to read